WO2004064764A3 - Substituted alkyl amido piperidines - Google Patents
Substituted alkyl amido piperidines Download PDFInfo
- Publication number
- WO2004064764A3 WO2004064764A3 PCT/US2004/000175 US2004000175W WO2004064764A3 WO 2004064764 A3 WO2004064764 A3 WO 2004064764A3 US 2004000175 W US2004000175 W US 2004000175W WO 2004064764 A3 WO2004064764 A3 WO 2004064764A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- subject
- compound
- provides
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002509456A CA2509456A1 (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines |
MXPA05006956A MXPA05006956A (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines. |
JP2006500796A JP2006515618A (en) | 2003-01-14 | 2004-01-06 | Substituted alkylamide piperidines |
US10/541,991 US20060217418A1 (en) | 2001-07-05 | 2004-01-06 | Substituted alkyl amido piperidines |
EP04700366A EP1590326A4 (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines |
NZ540366A NZ540366A (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines |
BR0406725-8A BRPI0406725A (en) | 2003-01-14 | 2004-01-06 | Compound, pharmaceutical composition, process for preparing it, and methods for treating an individual suffering from an affective disorder, treating an individual suffering from an urinary disorder, and treating an individual suffering from an eating disorder |
AU2004206794A AU2004206794A1 (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines |
EA200501122A EA009818B1 (en) | 2003-01-14 | 2004-01-06 | Substituted alkyl amido piperidines |
UAA200506356A UA79659C2 (en) | 2003-01-14 | 2004-06-01 | Substituted alkylamidopiperidines |
IS7860A IS7860A (en) | 2003-01-14 | 2005-05-23 | Substituted alkyl amido piperidine |
IL169637A IL169637A0 (en) | 2003-01-14 | 2005-07-11 | Substituted alkyl amido piperidines |
NO20053838A NO20053838L (en) | 2003-01-14 | 2005-08-15 | Substituted alkyl amido-piperidines |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/345,063 US7105544B2 (en) | 2001-07-05 | 2003-01-14 | Substituted alkyl amido piperidines |
US10/345,063 | 2003-01-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004064764A2 WO2004064764A2 (en) | 2004-08-05 |
WO2004064764A3 true WO2004064764A3 (en) | 2005-01-13 |
Family
ID=32069536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/000175 WO2004064764A2 (en) | 2001-07-05 | 2004-01-06 | Substituted alkyl amido piperidines |
Country Status (21)
Country | Link |
---|---|
US (2) | US7105544B2 (en) |
EP (1) | EP1590326A4 (en) |
JP (1) | JP2006515618A (en) |
KR (1) | KR20060002747A (en) |
CN (1) | CN1735595A (en) |
AR (1) | AR042839A1 (en) |
AU (1) | AU2004206794A1 (en) |
BR (1) | BRPI0406725A (en) |
CA (1) | CA2509456A1 (en) |
CL (1) | CL2004000064A1 (en) |
CO (1) | CO5590901A2 (en) |
EA (1) | EA009818B1 (en) |
IL (1) | IL169637A0 (en) |
IS (1) | IS7860A (en) |
MX (1) | MXPA05006956A (en) |
NO (1) | NO20053838L (en) |
NZ (1) | NZ540366A (en) |
PL (1) | PL378394A1 (en) |
UA (1) | UA79659C2 (en) |
WO (1) | WO2004064764A2 (en) |
ZA (1) | ZA200504218B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105544B2 (en) * | 2001-07-05 | 2006-09-12 | Synaptic Pharmaceutical Corporation | Substituted alkyl amido piperidines |
US20060009461A1 (en) * | 2002-05-23 | 2006-01-12 | Bhatia Pramila A | Acetamides and benzamides that are useful in treating sexual dysfunction |
WO2003099266A2 (en) * | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
US20040029887A1 (en) * | 2002-05-23 | 2004-02-12 | Bhatia Pramila A. | Acetamides and benzamides that are useful in treating sexual dysfunction |
EP1595867A4 (en) * | 2003-02-10 | 2008-05-21 | Banyu Pharma Co Ltd | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
US7783672B2 (en) * | 2003-04-09 | 2010-08-24 | Microsoft Corporation | Support mechanisms for improved group policy management user interface |
JP5094394B2 (en) * | 2005-04-20 | 2012-12-12 | 武田薬品工業株式会社 | Fused heterocyclic compounds |
WO2007090068A2 (en) * | 2006-01-27 | 2007-08-09 | Fibrogen, Inc. | Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
WO2009041567A1 (en) * | 2007-09-27 | 2009-04-02 | Banyu Pharmaceutical Co., Ltd. | Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
US10793515B2 (en) | 2008-03-19 | 2020-10-06 | Aurimmed Pharma, Inc. | Compounds advantageous in the treatment of central nervous system diseases and disorders |
KR101672884B1 (en) * | 2008-03-19 | 2016-11-04 | 오림드 파마, 인코포레이티드 | Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
EP2272841A1 (en) * | 2008-03-28 | 2011-01-12 | Banyu Pharmaceutical Co., Ltd. | Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
WO2010050456A1 (en) * | 2008-10-30 | 2010-05-06 | 萬有製薬株式会社 | Piperidine compound having di- or tri-arylmethyl structure |
JP6229896B2 (en) | 2013-01-21 | 2017-11-15 | 国立大学法人大阪大学 | Phenoxyalkylamine compound |
CN105431435A (en) * | 2013-06-07 | 2016-03-23 | 拜耳制药股份公司 | Substituted triazolopyridines having activity as MPS-1 inhibitors |
JP6461938B2 (en) * | 2014-05-28 | 2019-01-30 | アステラス製薬株式会社 | Pyridine derivatives |
CN105279394B (en) * | 2015-10-13 | 2017-12-26 | 山西农业大学 | Method for neuropeptide receptor screening |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004027A1 (en) * | 2001-07-05 | 2003-01-16 | Synaptic Pharmaceutical Corporation | Substituted anilinic piperidines as mch selective antagonists |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459151A (en) | 1993-04-30 | 1995-10-17 | American Home Products Corporation | N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents |
SE9803518D0 (en) | 1998-10-15 | 1998-10-15 | Astra Pharma Prod | Novel compounds |
US20030082623A1 (en) | 1998-12-31 | 2003-05-01 | Beth Borowsky | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US20040038855A1 (en) * | 1999-12-30 | 2004-02-26 | Salon John A. | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
CA2384358A1 (en) | 2000-07-05 | 2002-01-10 | Synaptic Pharmaceutical Corporation | Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
EP1299362A4 (en) | 2000-07-05 | 2004-11-03 | Synaptic Pharma Corp | Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
US6720324B2 (en) * | 2000-07-05 | 2004-04-13 | Synaptic Pharmaceutical Corporation | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
FR2815032B1 (en) | 2000-10-10 | 2003-08-08 | Pf Medicament | NOVEL AMINOPHENYL PIPERAZINE OR AMINO PHENYL PIPERIDE DERIVATIVES PRENYL TRANSFERASE PROTEIN INHIBITORS AND PREPARATIONS THEREOF |
US6727264B1 (en) | 2001-07-05 | 2004-04-27 | Synaptic Pharmaceutical Corporation | Substituted anilinic piperidines as MCH selective antagonists |
US7105544B2 (en) * | 2001-07-05 | 2006-09-12 | Synaptic Pharmaceutical Corporation | Substituted alkyl amido piperidines |
US7199135B2 (en) * | 2001-07-05 | 2007-04-03 | H. Lundbeck A/S | Substituted alkyl amido piperidines |
UA77814C2 (en) | 2002-07-03 | 2007-01-15 | Lundbeck & Co As H | Spirocyclic piperidines as antagonists of mch1 and use thereof |
UA77536C2 (en) | 2002-07-03 | 2006-12-15 | Lundbeck & Co As H | Secondary aminoaniline piperidines as mch1 antagonists and their use |
WO2004058727A1 (en) | 2002-12-20 | 2004-07-15 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
-
2003
- 2003-01-14 US US10/345,063 patent/US7105544B2/en not_active Expired - Fee Related
-
2004
- 2004-01-06 WO PCT/US2004/000175 patent/WO2004064764A2/en active Application Filing
- 2004-01-06 JP JP2006500796A patent/JP2006515618A/en not_active Withdrawn
- 2004-01-06 PL PL378394A patent/PL378394A1/en not_active Application Discontinuation
- 2004-01-06 BR BR0406725-8A patent/BRPI0406725A/en not_active IP Right Cessation
- 2004-01-06 CN CNA2004800020809A patent/CN1735595A/en active Pending
- 2004-01-06 CA CA002509456A patent/CA2509456A1/en not_active Abandoned
- 2004-01-06 US US10/541,991 patent/US20060217418A1/en not_active Abandoned
- 2004-01-06 MX MXPA05006956A patent/MXPA05006956A/en not_active Application Discontinuation
- 2004-01-06 EP EP04700366A patent/EP1590326A4/en not_active Withdrawn
- 2004-01-06 KR KR1020057013094A patent/KR20060002747A/en not_active Application Discontinuation
- 2004-01-06 AU AU2004206794A patent/AU2004206794A1/en not_active Abandoned
- 2004-01-06 EA EA200501122A patent/EA009818B1/en not_active IP Right Cessation
- 2004-01-06 NZ NZ540366A patent/NZ540366A/en unknown
- 2004-01-12 AR ARP040100069A patent/AR042839A1/en not_active Application Discontinuation
- 2004-01-16 CL CL200400064A patent/CL2004000064A1/en unknown
- 2004-06-01 UA UAA200506356A patent/UA79659C2/en unknown
-
2005
- 2005-05-23 IS IS7860A patent/IS7860A/en unknown
- 2005-05-24 ZA ZA200504218A patent/ZA200504218B/en unknown
- 2005-07-11 IL IL169637A patent/IL169637A0/en unknown
- 2005-07-21 CO CO05072012A patent/CO5590901A2/en not_active Application Discontinuation
- 2005-08-15 NO NO20053838A patent/NO20053838L/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004027A1 (en) * | 2001-07-05 | 2003-01-16 | Synaptic Pharmaceutical Corporation | Substituted anilinic piperidines as mch selective antagonists |
Also Published As
Publication number | Publication date |
---|---|
MXPA05006956A (en) | 2005-10-26 |
JP2006515618A (en) | 2006-06-01 |
EP1590326A4 (en) | 2008-04-30 |
EP1590326A2 (en) | 2005-11-02 |
NO20053838L (en) | 2005-08-15 |
CA2509456A1 (en) | 2004-08-05 |
US7105544B2 (en) | 2006-09-12 |
AR042839A1 (en) | 2005-07-06 |
WO2004064764A2 (en) | 2004-08-05 |
CL2004000064A1 (en) | 2005-03-18 |
PL378394A1 (en) | 2006-04-03 |
US20040073036A1 (en) | 2004-04-15 |
EA200501122A1 (en) | 2006-02-24 |
US20060217418A1 (en) | 2006-09-28 |
ZA200504218B (en) | 2006-07-26 |
UA79659C2 (en) | 2007-07-10 |
CN1735595A (en) | 2006-02-15 |
BRPI0406725A (en) | 2005-12-20 |
US20060041139A9 (en) | 2006-02-23 |
IS7860A (en) | 2005-05-23 |
AU2004206794A1 (en) | 2004-08-05 |
KR20060002747A (en) | 2006-01-09 |
CO5590901A2 (en) | 2005-12-30 |
IL169637A0 (en) | 2007-07-04 |
NZ540366A (en) | 2008-01-31 |
EA009818B1 (en) | 2008-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050145L (en) | Spirocyclic piperidines as MCH1 antagonists and applications thereof | |
WO2004064764A3 (en) | Substituted alkyl amido piperidines | |
WO2002060392A3 (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
UA49796C2 (en) | paroxetine hydrochloride anhydrate, method for preparing the above, paroxetine hydrochloride, method of preparing the above, method of treating and/or diseases preventing and pharmaceutical composition | |
NZ530221A (en) | Substituted anilinic piperidines as MCH selective antagonists | |
WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
YU59602A (en) | Aryl fused azapolycyclic compounds | |
NO20050113L (en) | Secondary amino-anilinic piperidines as MCH1 antagonists and uses thereof | |
HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
WO2002044174A3 (en) | 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors | |
UA85575C2 (en) | 4-aryl piperidines | |
WO2002102978A3 (en) | Human growth hormone antagonists | |
WO2004093789A3 (en) | Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
WO2006041636A3 (en) | Amino substituted aryloxybenzylpiperidine derivatives | |
YU60803A (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
WO2006041635A8 (en) | Arylthiobenzylpiperidine derivatives | |
WO2004034967A3 (en) | 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety | |
WO2002056869A3 (en) | Method for treating sexual disorders | |
MY133957A (en) | "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1-2005-501046 Country of ref document: PH |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005/04218 Country of ref document: ZA Ref document number: 200504218 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 540366 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2509456 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004700366 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/006956 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004206794 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006217418 Country of ref document: US Ref document number: 10541991 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 169637 Country of ref document: IL Ref document number: 20048020809 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 378394 Country of ref document: PL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057013094 Country of ref document: KR Ref document number: 2006500796 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 05072012 Country of ref document: CO |
|
WWP | Wipo information: published in national office |
Ref document number: 2004206794 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1886/CHENP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200501122 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 2004700366 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0406725 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057013094 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10541991 Country of ref document: US |